Trim 12-15% in 2-3 sessions into $940-$950 relief; hard stop at $894, full exit below $880 weekly
Underweight rating with 12-15% trim calibrated via binding prior lessons (9/10, 9/16, 9/22, 9/23). Hard stop at $894 daily close (2x ATR); full exit on weekly close below $880 on expansion volume. Re-engagement requires confirmed close above $950.49 with MACD/RSI confirmation. Pure Hold rejected based on 9/17/9/21/9/22/9/23 sequence producing -0.7% to -1.3% alpha across four iterations. 20-30% trim rejected per 9/10/9/16 lessons on buyback floors for high-beta compounders. Buy rating rejected; averaging into broken MAs with accelerating MACD ahead of binary catalyst converts corrections into capital events.
| Position | Action |
|---|---|
| Price reaching $940-$950 relief zone (200 SMA area) | Scale into trim 12-15% of target GS allocation |
| Weekly close below $880 on expansion volume | Full-exit escalation |
| Residual position with material exposure | Acceptable small protective-put overlay as complement to directional sizing |
Goldman Sachs is a premium franchise on sale at a growth-stock multiple, with 92% YoY EPS growth and a 12.5x forward P/E that prices in no growth, making the technical pullback a gift rather than a warning.
| Indicator | Value | Signal |
|---|---|---|
| close | 923.29 | neutral |
| close_10_ema | 961.53 | bearish |
| close_50_sma | 1024.50 | bearish |
| close_200_sma | 950.49 | neutral |
| rsi | 32.72 | bearish |
| macd | -25.49 | bearish |
| macd_signal | -17.09 | bearish |
| macd_histogram | -8.40 | bearish |
| bollinger_lower_band | 914.92 | bearish |
| bollinger_upper_band | 1078.52 | neutral |
| atr |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Q3 2026 earnings mid-October printing >$18 EPS with stable comp discipline and intact backlog
Then: Full restoration of target position
↩ rebuts: “Bear's framing of higher rates as a headwind that pressures equity multiples”
EV: +11% to +17% (targets: $961 (10 EMA), $1,024 (50 SMA), $1,078 (Boll upper))
Goldman Sachs is a cyclical franchise at its peak, not a mispriced growth story — Q2 2026's 92% EPS growth is a backward-looking trap against easy comps, the technical breakdown is already underway (price below 200 SMA, MACD at -25.49), and the macro environment (10Y at 2007 highs, D/E at 725x) creates asymmetric downside risk heading into a Q3 earnings report that Deutsche Bank already warned will be soft.
EV: -$180 to -$215 (target $850-$787 from ~$970 entry, worst-case $750-$780) · concedes: Higher rates do boost NII in the near term; Q2 2026 earnings were strong in absolute terms; RSI at 32.72 does create a potential divergence setup; Palmer Square acquisition adds some CLO AUM; Cyera investment is a growth equity stake in a hot sector
→ vs conservative: The 'broken technicals' argument is an excuse to hide; RSI at 32.7 and Bollinger Band pierce at 914.68 are statistical extremes signaling capitulation, not reasons to avoid the stock
→ vs conservative: Deutsche Bank comparison is flawed; GS has record IB backlog, stronger trading franchise, and expanding AWM—bear case is already priced in
→ vs conservative: Waiting for 200 SMA at 950.49 to resolve means paying 3% more for the same setup; breaking below 900 would still be an attractive entry at 9.5x forward earnings
→ vs neutral: Being cautious fights the Fed; the hawkish stance creates the ideal macro environment for Goldman with steeper curve and higher long-end yields
→ vs neutral: HOLD is the 'safe-sounding decision that delivers mediocre returns'; the asymmetric bet is clear with double-digit EPS growth and 17% ROE at current levels
| 27.14 |
| neutral |
Support: 914.68 · 914.92 · 950.49 · 900 | Resistance: 950.49 · 961.53 · 1024.5 · 1078.52
GS is in a confirmed near-term downtrend with price piercing the Bollinger Lower Band intraday (914.68 vs 914.92), sitting approximately 2.9% below the 200 SMA (950.49) which remains the last major long-term support line as it is still rising. MACD has confirmed a bearish crossover with the histogram widening to -8.40, indicating accelerating selling momentum, while RSI at 32.72 is approaching oversold territory with potential bullish divergence forming versus the September 16 low. The recommended action is HOLD; traders should monitor for either a reclaim above 950 with rising RSI for a relief bounce opportunity, or a confirmed daily close below 914.68 to validate further downside toward the 774-787 area.
Market Cap
$268.84B
P/E (TTM)
14.25x
Forward P/E
12.47x
PEG Ratio
1.16
Price / Book
2.55x
EPS (TTM)
$64.80
Forward EPS
$74.03
Dividend Yield
2.14%
Beta
1.28
52-Week High
$1,153.99
52-Week Low
$740.01
50-Day MA
$1,028.49
200-Day MA
$958.63
TTM Revenue
$67.57B
TTM Net Income
$19.98B
Profit Margin
31.04%
Operating Margin
42.18%
ROE
16.90%
ROA
1.07%
Debt / Equity
725.4x
Current Ratio
1.56
Book Value / Share
$362.05
Q2 2026 Revenue
$20.34B
Q2 2026 Net Income
$6.63B
Q2 2026 Diluted EPS
$20.98
YoY Revenue Growth (Q2 2026)
39%
YoY EPS Growth (Q2 2026)
92%
Net Interest Income (Q2 2026)
$3.95B
Net Interest Income (Q2 2025)
$3.10B
SG&A (Q2 2026)
$6.30B
Compensation Expenses (Q2 2026)
$6.10B
Total Assets (Q2 2026)
$2,127.7B
Total Assets (Q2 2025)
$1,785.0B
Total Liabilities (Q2 2026)
$2,005.0B
Total Liabilities (Q2 2025)
$1,660.9B
Stockholders Equity (Q2 2026)
$122.7B
Stockholders Equity (Q2 2025)
$124.1B
Cash & Equivalents (Q2 2026)
$187.3B
Long-Term Debt (Q2 2026)
$359.5B
Total Debt (Q2 2026)
$475.0B
Net Loans (Q2 2026)
$260.9B
Receivables (Q2 2026)
$250.3B
Trading Securities (Q2 2026)
$538.6B
Investments & Advances (Q2 2026)
$794.2B
Free Cash Flow (Q2 2026)
$5.60B
Share Buybacks (Q2 2026)
$4.68B
Dividends Paid (Q2 2026)
$1.60B
CapEx (Q2 2026)
$0.50B
Long-Term Debt Issuance (Q2 2026)
$54.72B
Forward EPS Growth
14%
Strengths
Concerns
Goldman Sachs delivered a standout Q2 2026 with EPS of $20.98 (up ~92% YoY) and revenue of $20.34B (up 39% YoY), driven by robust capital markets activity and expanded net interest income. The firm's 17% ROE, 42% operating margin, and aggressive capital return ($6B+ quarterly) highlight franchise quality and operating leverage. While the stock trades below both its 50-day ($1,028) and 200-day ($958) moving averages — offering an attractive entry point — the forward P/E of 12.47x with 14% EPS growth and a 2.14% dividend yield presents a compelling risk/reward for patient investors willing to manage a 1.28 beta cyclical profile.
Macro: Sharp repricing higher in Treasury yields (10Y at highest since 2007, 30Y at highest since 2004) driven by Fed pricing rather than fiscal fears; market now pricing in a Fed rate hike at October 27 FOMC meeting. Goldman's own economics team has doubled down on a hawkish call: one more 25bp hike at Oct. 27, then Fed is "done for this cycle." Prediction market shows 97% implied probability of no Fed rate cuts in 2026 (rising +1.6pp on the week, $8.5M volume). US recession odds at 10% (soft landing base case intact). Oil around $100/bbl with Hormuz diplomacy in focus.